Brokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $97.67
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research ...
Truist Financial Keeps Their Buy Rating on Larimar Therapeutics (LRMR)
Truist Financial analyst Joon Lee maintained a Buy rating on Larimar Therapeutics (LRMR – Research Report) today. The company’s shares closed ...
H.C. Wainwright Sticks to Their Buy Rating for Clene (CLNN)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Clene (CLNN – Research Report) today and set a price target of $31.00. The ...
Zacks Investment Research on MSN1d
Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know
The most recent trading session ended with Viking Therapeutics, Inc. (VKTX) standing at $29.28, reflecting a +1.14% shift from the previouse trading day's closing. The stock's change was less than the ...
Novo adds to obesity drug pipeline via $200M deal with China-based biotech
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Market Whales and Their Recent Bets on VKTX Options
Currently trading with a volume of 1,145,610, the VKTX's price is down by -1.23%, now at $28.0. RSI readings suggest the ...
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
Viking Therapeutics stock is down 52% over the trailing-12-month period. However, many Wall Street analysts remain ...